Data incompatibility of adverse event reports electronically submitted to the AERS database

Comment

. 2008 Feb;17(2):212-3.

doi: 10.1002/pds.1537.

Comment

Lucas M Glass. Pharmacoepidemiol Drug Saf. 2008 Feb.

. 2008 Feb;17(2):212-3.

doi: 10.1002/pds.1537.

No abstract available

Comment on

Accelerating statistical research in drug safety.
Bilker W, Gogolak V, Goldsmith D, Hauben M, Herrera G, Hochberg A, Jolley S, Kulldorff M, Madigan D, Nelson R, Shapiro A, Shmueli G. Bilker W, et al. Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):687-8. doi: 10.1002/pds.1267. Pharmacoepidemiol Drug Saf. 2006. PMID: 16941519 No abstract available.

Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
Huang L, Zalkikar J, Tiwari RC. Huang L, et al. J Biopharm Stat. 2013;23(1):178-200. doi: 10.1080/10543406.2013.736810. J Biopharm Stat. 2013. PMID: 23331230
Drug safety special: chasing shadows.
Frantz S. Frantz S. Nature. 2005 Mar 31;434(7033):557-8. doi: 10.1038/434557a. Nature. 2005. PMID: 15800592 No abstract available.
A potential competition bias in the detection of safety signals from spontaneous reporting databases.
Pariente A, Didailler M, Avillach P, Miremont-Salamé G, Fourrier-Reglat A, Haramburu F, Moore N. Pariente A, et al. Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1166-71. doi: 10.1002/pds.2022. Pharmacoepidemiol Drug Saf. 2010. PMID: 20848561
Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
Brajovic S, Piazza-Hepp T, Swartz L, Dal Pan G. Brajovic S, et al. Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):565-70; discussion 571-2. doi: 10.1002/pds.3223. Epub 2012 Feb 22. Pharmacoepidemiol Drug Saf. 2012. PMID: 22359404 Review.
Pregnancy exposure registries: academic opportunities and industry responsibility.
Wyszynski DF. Wyszynski DF. Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):93-101. doi: 10.1002/bdra.20525. Birth Defects Res A Clin Mol Teratol. 2009. PMID: 19107953 Review.